186 related articles for article (PubMed ID: 22469983)
1. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
[TBL] [Abstract][Full Text] [Related]
2. Regulation and tumor-suppressive function of the miR-379/miR-656 (C14MC) cluster in cervical cancer.
Srinath S; Jishnu PV; Varghese VK; Shukla V; Adiga D; Mallya S; Chakrabarty S; Sharan K; Pandey D; Chatterjee A; Kabekkodu SP
Mol Oncol; 2024 Jun; 18(6):1608-1630. PubMed ID: 38400534
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
Li W; Liang J; Zhang Z; Lou H; Zhao L; Xu Y; Ou R
Oncol Rep; 2017 May; 37(5):2743-2750. PubMed ID: 28393232
[TBL] [Abstract][Full Text] [Related]
4. miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
Zhao JL; Zhang L; Guo X; Wang JH; Zhou W; Liu M; Li X; Tang H
IUBMB Life; 2015 May; 67(5):380-94. PubMed ID: 25988335
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
Wang X; Tang S; Le SY; Lu R; Rader JS; Meyers C; Zheng ZM
PLoS One; 2008 Jul; 3(7):e2557. PubMed ID: 18596939
[TBL] [Abstract][Full Text] [Related]
6. miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.
Cheng L; Kong B; Zhao Y; Jiang J
Oncol Lett; 2018 Mar; 15(3):3075-3080. PubMed ID: 29456720
[TBL] [Abstract][Full Text] [Related]
7. MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression.
Dong X; Zhan Y; Li S; Yang M; Gao Y
Sci Rep; 2024 Mar; 14(1):6129. PubMed ID: 38480859
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma.
Duan Z; Shen J; Yang X; Yang P; Osaka E; Choy E; Cote G; Harmon D; Zhang Y; Nielsen GP; Spentzos D; Mankin H; Hornicek F
J Orthop Res; 2014 May; 32(5):695-701. PubMed ID: 24501096
[TBL] [Abstract][Full Text] [Related]
9. miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma.
Luo Y; Sun R; Zhang J; Sun T; Liu X; Yang B
Am J Transl Res; 2015; 7(10):2007-14. PubMed ID: 26692944
[TBL] [Abstract][Full Text] [Related]
10. Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment.
Liao YQ; Fang BB; Wu QX; Dong WY; Deng GM
J Recept Signal Transduct Res; 2023 Aug; 43(4):93-101. PubMed ID: 38070127
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications.
Dutta P; Pal D; Sultana F; Mandal RK; Roy A; Panda CK
Reprod Sci; 2024 Apr; 31(4):1122-1138. PubMed ID: 38012520
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women.
Tian Q; Li Y; Wang F; Li Y; Xu J; Shen Y; Ye F; Wang X; Cheng X; Chen Y; Wan X; Lu W; Xie X
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190727
[TBL] [Abstract][Full Text] [Related]
13. E4F1 is a master regulator of CHK1-mediated functions.
Grote D; Moison C; Duhamel S; Chagraoui J; Girard S; Yang J; Mayotte N; Coulombe Y; Masson JY; Brown GW; Meloche S; Sauvageau G
Cell Rep; 2015 Apr; 11(2):210-9. PubMed ID: 25843717
[TBL] [Abstract][Full Text] [Related]
14. miR-107 activates ATR/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1.
Zhou C; Li G; Zhou J; Han N; Liu Z; Yin J
PLoS One; 2014; 9(11):e111860. PubMed ID: 25386925
[TBL] [Abstract][Full Text] [Related]
15. The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells.
Llobet-Navas D; Rodriguez-Barrueco R; de la Iglesia-Vicente J; Olivan M; Castro V; Saucedo-Cuevas L; Marshall N; Putcha P; Castillo-Martin M; Bardot E; Ezhkova E; Iavarone A; Cordon-Cardo C; Silva JM
Mol Cell Biol; 2014 Dec; 34(23):4216-31. PubMed ID: 25266660
[TBL] [Abstract][Full Text] [Related]
16. Multistep model of cervical cancer: participation of miRNAs and coding genes.
Granados López AJ; López JA
Int J Mol Sci; 2014 Sep; 15(9):15700-33. PubMed ID: 25192291
[TBL] [Abstract][Full Text] [Related]
17. Metastatic heterogeneity of breast cancer cells is associated with expression of a heterogeneous TGFβ-activating miR424-503 gene cluster.
Li Y; Li W; Ying Z; Tian H; Zhu X; Li J; Li M
Cancer Res; 2014 Nov; 74(21):6107-18. PubMed ID: 25164015
[TBL] [Abstract][Full Text] [Related]
18. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the microRNA expression profile of cervical squamous cell carcinoma metastases.
Ding H; Wu YL; Wang YX; Zhu FF
Asian Pac J Cancer Prev; 2014; 15(4):1675-9. PubMed ID: 24641388
[TBL] [Abstract][Full Text] [Related]
20. miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells.
Zhang J; Zheng F; Yu G; Yin Y; Lu Q
Biochem Biophys Res Commun; 2013 Nov; 440(4):582-8. PubMed ID: 24120501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
